Back
  1. Home
  3. Detailled Reference
Request a copy
Paper published in a journal (Scientific congresses and symposiums)
99mTc rh-Annexin V (ApomateTM) as a marker of apoptosis resulting from chemotherapy : preliminary results.
BELHOCINE, T.; HUSTINX, Roland; JERUSALEM, Guy et al.
2000 • In Journal of Nuclear Medicine, 41 (SUPPL), p. 263
Peer Reviewed verified by ORBi
Permalink
https://hdl.handle.net/2268/167653
 

Files (1)Send toDetailsStatisticsBibliographySimilar publications

Files

Full Text
24 Belhocine T et al, J Nucl Med 2000 (abs).pdf
Publisher postprint (886.65 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to


Details


Disciplines :
Oncology
Radiology, nuclear medicine & imaging
Hematology
Author, co-author :
BELHOCINE, T.
HUSTINX, Roland  ;  Centre Hospitalier Universitaire de Liège - CHU > Médecine nucléaire et imagerie oncologique
JERUSALEM, Guy  ;  Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale
FASSOTTE, Marie-France ;  Centre Hospitalier Universitaire de Liège - CHU > Hématologie clinique
DUYSINX, Bernard ;  Centre Hospitalier Universitaire de Liège - CHU > Pneumologie-Allergologie
QUADEN, C.
RIGO, P.
Language :
English
Title :
99mTc rh-Annexin V (ApomateTM) as a marker of apoptosis resulting from chemotherapy : preliminary results.
Publication date :
2000
Event name :
SNM's 47th Annual Meeting
Event organizer :
SNM
Event place :
ST LOUIS - MISSOURI, United States
Event date :
3-7 JUIN 2000
Audience :
International
Journal title :
Journal of Nuclear Medicine
ISSN :
0161-5505
eISSN :
1535-5667
Publisher :
Society of Nuclear Medicine and Molecular Imaging, Reston, United States - Virginia
Volume :
41
Issue :
SUPPL
Pages :
263P
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 15 May 2014

Statistics

Number of views
29 (0 by ULiège)
Number of downloads
0 (0 by ULiège)
More statistics

Bibliography

Similar publications


Contact ORBi